Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
Among the IL-12 cytokines family, which plays critical roles in shaping immune responses, IL-12 is the first identified member and therefore has attracted much attention from investigators. Indeed, it has been found that IL-12 is implicated with series of diseases such as microbial infections, autoimmune diseases and cancers.
Moreover, this cytokine also has been demonstrated as a potent stimulator of several diseases characterized by inflammatory-induced bone destruction, including but no limitation to rheumatoid arthritis and periodontitis. Thus, understanding the various functions of IL-12 will be contributed to the investigation of those diseases mentioned above.
It has been shown that lL-12 is mainly produced by antigen-presenting cells (APCs), especially dendritic cells. Its primary function is to facilitate the development of native T cells into T-helper 1 (Th1) cells. Additionally, it also has been found that IL-12 has an ability to active T cells and nature killer (NK) cells, producing some inflammatory cytokines such as interferon gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α). Further studies have demonstrated that IFN-γ stimulation is contributed to strengthen the activity of phagocytic cells and the cytotoxic response of NK cells and CD8 T cells, making for the cell-mediated immune response. The major immunological function of IL-12 can be summarized as Figure 1.
Figure 1. Schematic drawing demonstrating the major immunological functions of IL-12. (Issaranggun B N A, et al.)
IL-12 signal transduction
Previous studies have shown that IL-12 is also involved in complex signaling in immunological cells like T cells, NK cells and DC cells (Figure 2).
Usually, IL-12 exerts its activities in immune system by binding to IL-12 receptors, which consist of two subunits of β1 and β2. The two subunits are associated with the Janus Kinase (JAK) family members Tyk2 and JAK2 respectively. Several studies have found that IL-12r-β1 is mainly contributing in ligand binding process, while IL-12R-β2 is responsible for signaling transduction process by phosphorylating the JAK2. Following, phospho-JAK2 leads to the activation of some transcription (STAT) molecules, especially STAT4. Reports found that dimerized STAT4 enters the cell nucleus, promoting or repressing the gene transcription. Thus, the STAT4 is the critical factor in IL-12 signaling pathway. Moreover, the induction of STAT4 by IL-12 may lead to promotion of IFN-γ production.
Figure 2. IL-12 signal transduction in T cells/NK cells and DC cells (Zundler S, et al.)
IL-12 and tumor suppression
Early studies have found that IL-12 involves the formation of tumor microenvironment via its various functions on different immune cells, mainly on lymphoid cells such as NK cells, T cells and ILCs. Studies have found that when treatment with IL-12, the secretion of IFN-γ is increased as a result of the stimulation of lymphoid cells, inducing most of the tumor-suppressing pathways (Figure 3). Additionally, IL-12 potentiate cytotoxic responses by NK cells and CD8 T cells (CD8+) cooperated with IFN-γ. Furthermore, IL-12 and IFN-γ potentiate cytotoxic responses by NK cells and CD8 T cells (CD8+). Moreover, studies have been demonstrated that the IFNγ also plays an important role in direct tumor vascular responses such as intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) up-regulation and inhibition of angiogenesis. And leukocyte recruitment to the tumor tissue is thought to be facilitated by the adhesion molecule. Besides, IFN-γ leads to the inhibition of angiogenesis by stimulating the myeloid cells, resulting in the increased secretion of Chemokine (C-X-C motif) ligand 9 (CXCL9) and CXCL10 and decreased production of VEGF and MMP-9.
Moreover, the stimulation of IL-12 on antigen presentation and cross-presentation by APCs has been found to promote the cytotoxic activity of CD8 T cells and cytokine response of CD4 T cells both. Additionally, the tumor suppressive effect also has been shown on GM-CSF which derived from T cells after the stimulation of IL-12.
Based on the suppression property of IL-12 on tumor, many therapeutic approaches such as recombinant IL-12 antibodies, transferred cells released IL-12 into tumors have been developed.
Figure 3. Cellular responses to IL-12 stimulation in the tumor tissue. (Tugues S, et al.)
In addition to the suppression role on tumor, IL-12 also exert important roles in periodontal disease and Central nervous system (CNS) autoimmune Disease. Thus, IL-12 is still a cytokine which possesses potent therapeutic function in clinic.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.